The Rab2A GTPase promotes breast cancer stem cells and tumorigenesis via erk signaling activation

Cell Reports

Volumn 11, Issue 1, 2015, Pages 111-124

  Luo, Man Li ^a,b   Gong, Chang ^b   Chen, Chun Hau ^a   Hu, Hai ^a   Huang, Pengyu ^a   Zheng, Min ^a,c   Yao, Yandan ^a,b   Wei, Shuo ^a   Wulf, Gerburg ^a   Lieberman, Judy ^a   Zhou, Xiao Zhen ^a   Song, Erwei ^b   Lu, Kun Ping ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DUAL SPECIFICITY PHOSPHATASE 6; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDYLPROLYL ISOMERASE PIN1; RAB2A PROTEIN; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; NIMA INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE; PIN1 PROTEIN, HUMAN; RAB PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM CELL; CANCER PATIENT; CANCER STEM CELL; CARCINOGENESIS; CELL ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME INACTIVATION; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STEM CELL EXPANSION; UPREGULATION; BIOSYNTHESIS; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MAPK SIGNALING; METABOLISM; PATHOLOGY; TRANSCRIPTION INITIATION;

BREAST NEOPLASMS; CARCINOGENESIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASTIC STEM CELLS; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE; RAB GTP-BINDING PROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 84927698559     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.03.002     Document Type: Article

References (57)

1. Aceto N., Sausgruber N., Brinkhaus H., Gaidatzis D., Martiny-Baron G., Mazzarol G., Confalonieri S., Quarto M., Hu G., Balwierz P.J., et al. Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop. Nat. Med. 2012, 18:529-537.
2. Akunuru S., Palumbo J., Zhai Q.J., Zheng Y. Rac1 targeting suppresses human non-small cell lung adenocarcinoma cancer stem cell activity. PLoS ONE 2011, 6:e16951.
3. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
4. Bardwell A.J., Abdollahi M., Bardwell L. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity. Biochem. J. 2003, 370:1077-1085.
5. Beroukhim R., Mermel C.H., Porter D., Wei G., Raychaudhuri S., Donovan J., Barretina J., Boehm J.S., Dobson J., Urashima M., et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905.
6. Bild A.H., Yao G., Chang J.T., Wang Q., Potti A., Chasse D., Joshi M.B., Harpole D., Lancaster J.M., Berchuck A., et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006, 439:353-357.
7. Bind E., Kleyner Y., Skowronska-Krawczyk D., Bien E., Dynlacht B.D., Sánchez I. A novel mechanism for mitogen-activated protein kinase localization. Mol. Biol. Cell 2004, 15:4457-4466.
8. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature 2001, 411:355-365.
9. Bonnefoix T., Bonnefoix P., Callanan M., Verdiel P., Sotto J.J. Graphical representation of a generalized linear model-based statistical test estimating the fit of the single-hit Poisson model to limiting dilution assays. J.Immunol. 2001, 167:5725-5730.
10. Cerami E., Gao J., Dogrusoz U., Gross B.E., Sumer S.O., Aksoy B.A., Jacobsen A., Byrne C.J., Heuer M.L., Larsson E., et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012, 2:401-404.
11. Chang C.J., Yang J.Y., Xia W., Chen C.T., Xie X., Chao C.H., Woodward W.A., Hsu J.M., Hortobagyi G.N., Hung M.C. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling. Cancer Cell 2011, 19:86-100.
12. Chen C.H., Chang C.C., Lee T.H., Luo M., Huang P., Liao P.H., Wei S., Li F.A., Chen R.H., Zhou X.Z., et al. SENP1 deSUMOylates and regulates Pin1 protein activity and cellular function. Cancer Res. 2013, 73:3951-3962.
13. Cheng K.W., Lahad J.P., Kuo W.L., Lapuk A., Yamada K., Auersperg N., Liu J., Smith-McCune K., Lu K.H., Fishman D., et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med. 2004, 10:1251-1256.
14. Chiu V.K., Bivona T., Hach A., Sajous J.B., Silletti J., Wiener H., Johnson R.L., Cox A.D., Philips M.R. Ras signalling on the endoplasmic reticulum and the Golgi. Nat. Cell Biol. 2002, 4:343-350.
15. Curtis C., Shah S.P., Chin S.F., Turashvili G., Rueda O.M., Dunning M.J., Speed D., Lynch A.G., Samarajiwa S., Yuan Y., et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012, 486:346-352. METABRIC Group.
16. Delcroix J.D., Valletta J.S., Wu C., Hunt S.J., Kowal A.S., Mobley W.C. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron 2003, 39:69-84.
17. Dontu G., Wicha M.S. Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia. J.Mammary Gland Biol. Neoplasia 2005, 10:75-86.
18. Eggenschwiler J.T., Espinoza E., Anderson K.V. Rab23 is an essential negative regulator of the mouse Sonic hedgehog signalling pathway. Nature 2001, 412:194-198.
19. Elenbaas B., Spirio L., Koerner F., Fleming M.D., Zimonjic D.B., Donaher J.L., Popescu N.C., Hahn W.C., Weinberg R.A. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 2001, 15:50-65.
20. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C.G., Liu S., et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567.
21. Goldenring J.R. A central role for vesicle trafficking in epithelial neoplasia: intracellular highways to carcinogenesis. Nat. Rev. Cancer 2013, 13:813-820.
22. Hauri H.P., Kappeler F., Andersson H., Appenzeller C. ERGIC-53 and traffic in the secretory pathway. J.Cell Sci. 2000, 113:587-596.
23. Hou Q., Wu Y.H., Grabsch H., Zhu Y., Leong S.H., Ganesan K., Cross D., Tan L.K., Tao J., Gopalakrishnan V., et al. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Cancer Res. 2008, 68:4623-4630.
24. Jacob A., Jing J., Lee J., Schedin P., Gilbert S.M., Peden A.A., Junutula J.R., Prekeris R. Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells. J.Cell Sci. 2013, 126:4647-4658.
25. Kao K.J., Chang K.M., Hsu H.C., Huang A.T. Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization. BMC Cancer 2011, 11:143.
26. Karlsson M., Mathers J., Dickinson R.J., Mandl M., Keyse S.M. Both nuclear-cytoplasmic shuttling of the dual specificity phosphatase MKP-3 and its ability to anchor MAP kinase in the cytoplasm are mediated by a conserved nuclear export signal. J.Biol. Chem. 2004, 279:41882-41891.
27. Lee T.H., Chen C.H., Suizu F., Huang P., Schiene-Fischer C., Daum S., Zhang Y.J., Goate A., Chen R.H., Zhou X.Z., Lu K.P. Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function. Mol. Cell 2011, 42:147-159.
28. Liu S., Wicha M.S. Targeting breast cancer stem cells. J.Clin. Oncol. 2010, 28:4006-4012.
29. Liu M., Casimiro M.C., Wang C., Shirley L.A., Jiao X., Katiyar S., Ju X., Li Z., Yu Z., Zhou J., et al. p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression invivo. Proc. Natl. Acad. Sci. USA 2009, 106:19035-19039.
30. Lu Z., Hunter T. Prolyl isomerase Pin1 in cancer. Cell Res. 2014, 24:1033-1049.
31. Lu K.P., Zhou X.Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:904-916.
32. Lu K.P., Hanes S.D., Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996, 380:544-547.
33. Luo M.L., Gong C., Chen C.H., Lee D.Y., Hu H., Huang P., Yao Y., Guo W., Reinhardt F., Wulf G., et al. Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer. Cancer Res. 2014, 74:3603-3616.
34. Monje P., Hernández-Losa J., Lyons R.J., Castellone M.D., Gutkind J.S. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J.Biol. Chem. 2005, 280:35081-35084.
35. Myant K.B., Cammareri P., McGhee E.J., Ridgway R.A., Huels D.J., Cordero J.B., Schwitalla S., Kalna G., Ogg E.L., Athineos D., et al. ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell 2013, 12:761-773.
36. Nakamura K., Greenwood A., Binder L., Bigio E.H., Denial S., Nicholson L., Zhou X.Z., Lu K.P. Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease. Cell 2012, 149:232-244.
37. Nam K.T., Lee H.J., Smith J.J., Lapierre L.A., Kamath V.P., Chen X., Aronow B.J., Yeatman T.J., Bhartur S.G., Calhoun B.C., et al. Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. J.Clin. Invest. 2010, 120:840-849.
38. Parker J.S., Mullins M., Cheang M.C., Leung S., Voduc D., Vickery T., Davies S., Fauron C., He X., Hu Z., et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J.Clin. Oncol. 2009, 27:1160-1167.
39. Reya T., Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850.
40. Rhodes D.R., Kalyana-Sundaram S., Mahavisno V., Varambally R., Yu J., Briggs B.B., Barrette T.R., Anstet M.J., Kincead-Beal C., Kulkarni P., et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007, 9:166-180.
41. Roskoski R. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol. Res. 2012, 66:105-143.
42. Rustighi A., Zannini A., Tiberi L., Sommaggio R., Piazza S., Sorrentino G., Nuzzo S., Tuscano A., Eterno V., Benvenuti F., et al. Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast. EMBO Mol. Med. 2014, 6:99-119.
43. Ryo A., Nakamura M., Wulf G., Liou Y.C., Lu K.P. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 2001, 3:793-801.
44. Schmidt M., Böhm D., von Törne C., Steiner E., Puhl A., Pilch H., Lehr H.A., Hengstler J.G., Kölbl H., Gehrmann M. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 2008, 68:5405-5413.
45. Schubbert S., Shannon K., Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 2007, 7:295-308.
46. Shin S., Dimitri C.A., Yoon S.O., Dowdle W., Blenis J. ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol. Cell 2010, 38:114-127.
47. Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 2009, 10:513-525.
48. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., Eaves C.J. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
49. Tanoue T., Adachi M., Moriguchi T., Nishida E. A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat. Cell Biol. 2000, 2:110-116.
50. Tisdale E.J., Balch W.E. Rab2 is essential for the maturation of pre-Golgi intermediates. J.Biol. Chem. 1996, 271:29372-29379.
51. Tong M., Chan K.W., Bao J.Y., Wong K.Y., Chen J.N., Kwan P.S., Tang K.H., Fu L., Qin Y.R., Lok S., et al. Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma. Cancer Res. 2012, 72:6024-6035.
52. Wellner U., Schubert J., Burk U.C., Schmalhofer O., Zhu F., Sonntag A., Waldvogel B., Vannier C., Darling D., zur Hausen A., et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 2009, 11:1487-1495.
53. Wulf G.M., Ryo A., Wulf G.G., Lee S.W., Niu T., Petkova V., Lu K.P. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 2001, 20:3459-3472.
54. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J.U., Xu J., Kuang J., Kirschner M.W., Fischer G., et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278:1957-1960.
55. Yoon C.H., Hyun K.H., Kim R.K., Lee H., Lim E.J., Chung H.Y., An S., Park M.J., Suh Y., Kim M.J., Lee S.J. The small GTPase Rac1 is involved in the maintenance of stemness and malignancies in glioma stem-like cells. FEBS Lett. 2011, 585:2331-2338.
56. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., Huang Y., Hu X., Su F., Lieberman J., Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007, 131:1109-1123.
57. Zhang M., Behbod F., Atkinson R.L., Landis M.D., Kittrell F., Edwards D., Medina D., Tsimelzon A., Hilsenbeck S., Green J.E., et al. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res. 2008, 68:4674-4682.